中外医疗
中外醫療
중외의료
CHINA FOREIGN MEDICAL TREATMENT
2015年
20期
117-118
,共2页
低分子肝素钙%法舒地尔%后循环缺血
低分子肝素鈣%法舒地爾%後循環缺血
저분자간소개%법서지이%후순배결혈
Low molecular heparin calcium%Method of shu%Posterior circulation ischemia
目的:探讨分低分子肝素钙联合法舒地尔治疗后循环缺血的临床疗效。方法整群选择该院2012年1月-2014年1月收治的63例后循环缺血患者为研究对象,并按治疗方法的不同将其分为治疗组33例,对照组30例。给予治疗组低分子肝素钙联合法舒地尔治疗,给予对照组常规治疗,对比两组治疗结果。结果两组治疗后PT、INR、APTT、Fb、PLT水平比较差异不显著,且两组治疗过程中均未出现不良反应。然而,治疗组治疗总有效率为93.94%;对照组为73.33%;治疗组明显大于对照组,两组比较差异具有统计学意义,P<0.05。结论相比于常规治疗手段,联合应用低分子肝素钙以及法舒地尔治疗后循环缺血的效果明显,治疗痊愈率高,不良反应少,因此该治疗方法值得临床推广应用。
目的:探討分低分子肝素鈣聯閤法舒地爾治療後循環缺血的臨床療效。方法整群選擇該院2012年1月-2014年1月收治的63例後循環缺血患者為研究對象,併按治療方法的不同將其分為治療組33例,對照組30例。給予治療組低分子肝素鈣聯閤法舒地爾治療,給予對照組常規治療,對比兩組治療結果。結果兩組治療後PT、INR、APTT、Fb、PLT水平比較差異不顯著,且兩組治療過程中均未齣現不良反應。然而,治療組治療總有效率為93.94%;對照組為73.33%;治療組明顯大于對照組,兩組比較差異具有統計學意義,P<0.05。結論相比于常規治療手段,聯閤應用低分子肝素鈣以及法舒地爾治療後循環缺血的效果明顯,治療痊愈率高,不良反應少,因此該治療方法值得臨床推廣應用。
목적:탐토분저분자간소개연합법서지이치료후순배결혈적림상료효。방법정군선택해원2012년1월-2014년1월수치적63례후순배결혈환자위연구대상,병안치료방법적불동장기분위치료조33례,대조조30례。급여치료조저분자간소개연합법서지이치료,급여대조조상규치료,대비량조치료결과。결과량조치료후PT、INR、APTT、Fb、PLT수평비교차이불현저,차량조치료과정중균미출현불량반응。연이,치료조치료총유효솔위93.94%;대조조위73.33%;치료조명현대우대조조,량조비교차이구유통계학의의,P<0.05。결론상비우상규치료수단,연합응용저분자간소개이급법서지이치료후순배결혈적효과명현,치료전유솔고,불량반응소,인차해치료방법치득림상추엄응용。
Objective To study the points of low molecular heparin calcium combined method of shu, clinical curative effect for the treatment of posterior circulation ischemia. Methods 63 cases of patients with posterior circulation ischemia in our hospital as the research object, and follow the different treatments will be divided into the treatment group (33 cases, control group 30 cases. Treated group and low molecular heparin calcium combined method of shu ground treatment, give control group routine treatment, compared two groups of treatment results. Results Two groups after treatment, INR, APTT and PT Fb, PLT level comparative dif-ference was not significant, and no adverse reactions occurred in the process of treatment of the two groups. However, treatment group total effective rate was 93.94%; The control group is 73.33%; Treatment group was significantly greater than the control group, two groups compare differences statistically significant, (P<0.05). Conclusion Compared with the conventional treatment, combined use of low molecular heparin calcium and shu, the effect of the treatment of posterior circulation ischemia, treatment of high cure rate, less adverse reaction, so the treatment is worthy of clinical application.